Predictions for Health Tech Innovators: 2023


By Josh Gray What lies ahead for innovative health technologies companies in 2023? Heading into 2022, we predicted a tough year for startups. If anything, we understated the situation: the funding environment is dramatically tougher, with little prospect of relief in the near future. We also anticipated that “early advocates using AI in controlled settings […]

Recent Conference Take-Aways

David Clain

By Paul Cummings David Clain moderating the Cost and Quality Analytics Panel at FLAACOs Keynote speaker Dr. Anthony Fauci at the 2022 APG Colloquium  HDAI recently participated in both the Florida Association of Accountable Care Organizations (FLAACOs) conference in Orlando, FL and the APG (America’s Physician Groups) Colloquium 2022 – America’s Physician Groups in Washington DC. […]

The Next Evolution

By Nidhee Krishnan Nidhee is a product manager with HDAI, who transitioned a year ago from bedside care to healthcare innovation. Prior to this career change, she was in her second year of medical school and was conducting clinical research in parallel. She took a few moments to briefly share with us how her experiences in […]

The Risk Stratification Index (RSI) is proven again to be a reliable baseline risk predictor

Predictive Analytics

11.03.21 By Paul Manberg How do we get more value out of limited health care dollars? One strategy is to use a risk stratification tool that helps avoid expensive downstream events by identifying which patients should be selected for additional surveillance and earlier intervention if needed. AI-driven predictors that use administrative data are attractive because the data is readily […]

New Research Explores Immuno-oncology Effectiveness for Lung Cancer in Medicare Population 

JAMA Network

05.21.21 Findings from HDAI and Dana-Farber Cancer Institute Real-world Evidence Study of 20,000 Medicare Patients Shows Shorter Survival Times than Observed in Clinical Trials   BOSTON, May 21, 2021 /PRNewswire/ — Health Data Analytics Institute (HDAI) – an innovator in healthcare AI solutions – and researchers at Dana-Farber Cancer Institute today announced publication of  findings exploring the effectiveness of immune checkpoint inhibition for […]